Greenleaf Trust Sells 14,453 Shares of DuPont de Nemours, Inc. $DD

Key Points

• Greenleaf Trust cut its DuPont de Nemours stake by 71.8% in the second quarter, selling 14,453 shares and retaining 5,672 shares valued at approximately $769,000. Institutional investors collectively own 73.96% of the company.
• DuPont reported quarterly EPS of $1.88, beating estimates of $1.76, while revenue rose 4% year over year to $1.82 billion. The stock opened at $132.07, below its 50-day and 200-day moving averages.
• Analysts maintain a “Moderate Buy” consensus with an average price target of $166.60, despite one sell rating. The company announced a quarterly dividend of $0.60 per share, equivalent to a 1.8% annualized yield.

Greenleaf Trust trimmed its stake in DuPont de Nemours, Inc. (NYSE:DD - Free Report) by 71.8% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,672 shares of the basic materials company's stock after selling 14,453 shares during the period. Greenleaf Trust's holdings in DuPont de Nemours were worth $769,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the stock. Boussard & Gavaudan Gestion Sas bought a new stake in DuPont de Nemours during the second quarter valued at about $4,912,000. Brooks Moore & Associates Inc. bought a new position in shares of DuPont de Nemours in the second quarter worth about $480,000. Public Employees Retirement System of Ohio bought a new position in shares of DuPont de Nemours in the second quarter worth about $11,049,000. Birmingham Capital Management Co. Inc. AL purchased a new position in shares of DuPont de Nemours during the 2nd quarter valued at about $494,000. Finally, First Bancorp Inc ME purchased a new position in shares of DuPont de Nemours during the 2nd quarter valued at about $90,000. 73.96% of the stock is owned by institutional investors.

DuPont de Nemours Stock Down 1.9%

NYSE DD opened at $132.07 on Wednesday. DuPont de Nemours, Inc. has a 12 month low of $92.49 and a 12 month high of $157.98. The company has a current ratio of 2.43, a quick ratio of 1.82 and a debt-to-equity ratio of 0.23. The stock has a market cap of $17.83 billion, a PE ratio of 293.55, a P/E/G ratio of 1.23 and a beta of 1.06. The stock's 50 day moving average is $138.71 and its 200 day moving average is $141.01.

DuPont de Nemours (NYSE:DD - Get Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The basic materials company reported $1.88 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.76 by $0.12. The business had revenue of $1.82 billion during the quarter, compared to analyst estimates of $1.81 billion. DuPont de Nemours had a net margin of 0.67% and a return on equity of 6.92%. The company's revenue was up 4.0% on a year-over-year basis. During the same period last year, the firm posted $1.12 EPS. DuPont de Nemours has set its Q3 2026 guidance at 1.800-1.900 EPS. Research analysts predict that DuPont de Nemours, Inc. will post 7.27 EPS for the current fiscal year.

DuPont de Nemours Cuts Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Monday, August 31st will be given a dividend of $0.60 per share. The ex-dividend date is Monday, August 31st. This represents a $2.40 dividend on an annualized basis and a dividend yield of 1.8%. DuPont de Nemours's dividend payout ratio is currently 533.33%.

Analyst Upgrades and Downgrades

DD has been the subject of several analyst reports. BMO Capital Markets increased their target price on shares of DuPont de Nemours from $75.30 to $180.00 and gave the stock an "outperform" rating in a report on Tuesday, May 5th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of DuPont de Nemours from $174.00 to $180.00 and gave the company a "buy" rating in a report on Thursday, May 7th. Citigroup increased their price objective on shares of DuPont de Nemours from $168.00 to $170.00 and gave the stock a "buy" rating in a research note on Thursday, July 2nd. Weiss Ratings restated a "sell (d+)" rating on shares of DuPont de Nemours in a research report on Monday, August 3rd. Finally, UBS Group lifted their target price on shares of DuPont de Nemours from $175.00 to $178.00 and gave the company a "buy" rating in a research note on Wednesday, August 5th. Twelve equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, DuPont de Nemours has a consensus rating of "Moderate Buy" and an average price target of $166.60.

About DuPont de Nemours

DuPont de Nemours NYSE: DD is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.

DuPont's operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.